Related StoriesUnique, small protein cage developed to deliver chemotherapy chemicals directly to cancers cellsUnderstanding how schizophrenia impacts workings of the brainDiscovery can offer clues to how some viruses control expression of genetic materialAs life science discovery and development continues to move toward a better understanding of biological responses to disease, and comes with an increased emphasis on protein-structured therapeutics by pharmaceutical businesses, the necessity for automated, quality protein sample preparation and evaluation has become important.Improvements in response rates and resilience of response in the VR-CAP group, as compared with the R-CHOP group, were also noticed for investigator-assessed responses . Other Secondary End Points For R-CHOP versus VR-CAP, the median time to progression by independent assessment was 16.1 months versus 30.5 months , the median time to another antilymphoma therapy was 24.8 months versus 44.5 months , and the median treatment-free of charge interval was 20.5 months versus 40.6 months .